ABOUT THE PRODUCT
A first-in-class gene editing therapy for chronic Hepatitis B, utilizing the ARCUS platform to eliminate cccDNA and inactivate integrated HBV DNA.
Information is owner-confirmed
Last updated 3 weeks ago
Price range
Other products/services from Precision BioSciences, Inc.
ARCUS Genome Editing Platform
Biotechnology
N/A
Precision BioSciences, Inc.
United States (US)